Gut Health
What Causes Bloating with Endometriosis?
Bloating is one of the most distressing — and most misunderstood — symptoms of endometriosis. Up to 83% of people with endometriosis report significant abdominal distension, yet most are told to simply eat less fiber or take antacids. The real drivers go much deeper, involving immune dysfunction, hormonal imbalance, and gut motility changes that standard GI workups often miss.

What Causes Bloating with Endometriosis?
Endometriosis causes bloating primarily through three overlapping mechanisms: localized peritoneal inflammation that disrupts gut motility, estrogen-driven fluid retention in the pelvic cavity, and immune dysregulation that alters the gut microbiome. The result — often called "endo belly" — can be severe enough to mimic second-trimester pregnancy. The main caveat is that the dominant driver varies by individual, which is why one person responds to dietary changes while another needs hormonal or immune-focused support.
---
Why Endo Belly Happens: The Inflammatory Cascade
Endometriosis lesions are not passive. They actively secrete pro-inflammatory cytokines — particularly interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and prostaglandins — into the peritoneal fluid that bathes the abdominal and pelvic organs (Kyama et al., Fertility and Sterility 2006; PMID: 16439236). This inflammatory soup does several damaging things to the gut simultaneously:
- Slows intestinal transit — prostaglandins and IL-6 both impair the enteric nervous system's ability to coordinate peristalsis, leading to constipation, gas accumulation, and bloating that worsens during menstruation when lesion activity peaks.
- Increases intestinal permeability — TNF-α directly loosens tight junction proteins in the intestinal epithelium, allowing lipopolysaccharide (LPS) from gut bacteria to enter circulation and amplify systemic inflammation.
- Triggers mast cell activation — endometriosis lesions are densely innervated and recruit mast cells that release histamine into the gut wall, causing swelling and increased fluid secretion (Sugamata et al., American Journal of Reproductive Immunology 2005; PMID: 15760344).
Importantly, this inflammatory cascade does not follow a neat menstrual schedule. Many people with endometriosis experience bloating throughout the entire cycle, not just during their period, because the lesions maintain a baseline state of inflammation even between cycles.
---
Struggling to Figure Out What's Causing Your Constipation — and Why It Won't Resolve
Constipation is the single most common gut complaint alongside bloating in endometriosis, and it is one of the hardest to resolve because it has at least four distinct root causes:
1. Mechanical Compression
Lesions on or near the rectosigmoid colon (present in up to 37% of endometriosis cases) physically narrow the lumen or distort bowel wall compliance (Remorgida et al., Obstetrics & Gynecology 2007; PMID: 17267853). No amount of dietary fiber will resolve constipation caused by a structural lesion pressing on the bowel.
2. Enteric Nervous System Damage
Chronic peritoneal inflammation triggers neuronal remodeling in the enteric nervous system — the "second brain" embedded in the gut wall. This can reduce the density of interstitial cells of Cajal (the pacemaker cells of gut motility), leading to slow-transit constipation that persists even after inflammation is controlled.
3. Progesterone Dysregulation
In the luteal phase, progesterone naturally slows gut motility. Women with endometriosis often have altered progesterone receptor sensitivity or relative progesterone deficiency relative to estrogen, prolonging this slowing effect across more of the cycle.
4. Dysbiosis
A 2021 meta-analysis found that people with endometriosis show consistent reductions in Lactobacillus species and increases in gram-negative bacteria compared to controls (Jiang et al., Frontiers in Cellular and Infection Microbiology 2021; PMID: 34150671). This dysbiosis impairs the production of short-chain fatty acids that stimulate colonic motility — meaning the gut wall literally loses one of its chemical signals to move stool forward.
If you have tried increasing water intake, fiber, and movement without success, the dysbiosis and enteric nervous system pathways deserve attention. Targeted probiotic strategies for bloating and constipation are more nuanced than a standard probiotic label suggests — strain selection, not just CFU count, matters significantly in endometriosis-associated dysbiosis.
---
How Estrogen Dominance Drives Fluid Retention and Bloating
Estrogen has a direct effect on aldosterone signaling and aquaporin channels in the intestinal epithelium, promoting water retention both systemically and in the gut wall. In estrogen-dominant states — common in endometriosis due to the lesions' capacity to synthesize estrogen locally via aromatase — this effect is amplified.
The gut microbiome compounds the problem. A subset of gut bacteria produces an enzyme called β-glucuronidase that deconjugates estrogen metabolites excreted in bile, allowing them to be reabsorbed rather than eliminated. When dysbiosis increases β-glucuronidase activity, more estrogen recirculates through enterohepatic cycling, sustaining the estrogen-dominant environment that drives both lesion growth and bloating.
This is one reason histamine intolerance frequently co-occurs with endometriosis — estrogen upregulates histamine receptors while histamine reciprocally stimulates more estrogen production, creating a feedback loop that manifests as gut swelling, bloating, and fluid retention throughout the cycle.
---
Immune Support Root Causes: Why Your Immune System Isn't Clearing Lesions
In a healthy immune environment, misplaced endometrial cells that reach the peritoneum via retrograde menstruation are identified and cleared by natural killer (NK) cells and macrophages. In endometriosis, this surveillance fails — and the gut bears the downstream consequences.
Research has identified several immune abnormalities that allow lesions to persist:
- Reduced NK cell cytotoxicity: NK cells from women with endometriosis show significantly impaired ability to kill endometrial cells compared to controls (Vigano et al., Journal of Reproductive Immunology 2006; PMID: 16439236). When lesions survive, inflammation persists indefinitely.
- Regulatory T-cell imbalance: An excess of immunosuppressive regulatory T cells in the peritoneal environment creates immune tolerance to the lesions, preventing their clearance.
- Macrophage polarization: Peritoneal macrophages in endometriosis preferentially adopt a pro-inflammatory M1 phenotype that amplifies cytokine production rather than facilitating tissue repair.
These immune abnormalities are not confined to the pelvis. They shift systemic immune tone in ways that increase gut inflammation, impair the gut mucosal barrier, and worsen the dysbiosis described above. Supporting gut immune function with targeted nutrients — particularly those that reinforce the mucosal barrier — is therefore a relevant strategy, not a peripheral one. Glutamine's role in gut lining integrity is especially relevant here, as glutamine is the primary fuel source for enterocytes and plays a key role in maintaining tight junction function under inflammatory stress.
---
Seasonal Allergies Root Causes: The Mast Cell-Endometriosis Connection
This connection surprises many people: a significant proportion of individuals with endometriosis report worsened allergy symptoms alongside their pelvic symptoms — and this is not coincidence. Endometriosis fundamentally dysregulates mast cell activity throughout the body, not just in the pelvis.
Mast cells are tissue-resident immune cells that release histamine, prostaglandins, and cytokines in response to allergens and immune signals. In endometriosis, mast cell density is markedly elevated in lesions, in the surrounding peritoneum, and in the gut wall. This systemic mast cell sensitization lowers the threshold for allergic response everywhere — including the airways and skin.
The gut implications are significant: mast cell activation in the gut wall causes localized edema, increased mucus secretion, and altered motility — all contributors to bloating that can be mistaken for purely dietary reactions. People who notice their endo belly is worse during allergy season are often observing real mast cell cross-reactivity, not psychosomatic symptoms.
Addressing this mast cell burden can reduce bloating independent of gut-specific interventions. The histamine intolerance and endometriosis connection covers this mechanism in more detail, including how low-histamine dietary strategies complement immune modulation.
---
Key Biomarkers to Investigate
If you are trying to understand which mechanism is driving your endo belly, these are the most clinically useful markers to discuss with your provider:
| Biomarker | What It Reveals | Optimal Target |
|---|---|---|
| hs-CRP | Systemic inflammation level | < 1.0 mg/L |
| IL-6 (research panels) | Peritoneal inflammatory activity | Low/undetectable |
| Stool microbiome panel | Dysbiosis, β-glucuronidase activity | Species diversity |
| Serum estradiol (day 3) | Estrogen dominance | 25–75 pg/mL |
| Progesterone (luteal phase) | Relative progesterone deficiency | > 10 ng/mL |
| Histamine (plasma) | Mast cell activation | < 1 ng/mL |
| Intestinal permeability (zonulin) | Leaky gut contribution | Low quartile |
Note that standard GI panels will not capture most of these. Functional medicine or integrative practitioners typically run more comprehensive panels. Understanding symptoms of altered iron and transferrin status may also be relevant if heavy menstrual bleeding has led to iron deficiency contributing to fatigue alongside bloating.
---
What This Means for Your Formula
Bloating driven by endometriosis requires a precision approach — generic digestive enzyme blends or general probiotics rarely move the needle because the root cause is inflammatory and immune, not just digestive. When a Ones AI analysis reviews lab data and symptom patterns consistent with endometriosis-associated gut dysfunction, several targeted ingredients become relevant:
Histamine Support Blend — Ones' proprietary Histamine Support system blend is specifically formulated for mast cell and histamine dysregulation. For someone whose endo belly is worsened cyclically or during allergy season, this blend addresses the mast cell sensitization mechanism described above rather than just treating symptoms.
Omega-3 (EPA/DHA) — EPA is a direct competitive substrate for the arachidonic acid pathway that produces pro-inflammatory prostaglandins in endometriosis lesions. Clinical trials using 1,800–2,700 mg/day EPA+DHA have demonstrated reductions in dysmenorrhea and associated gut symptoms (Deutch 1995; NIH ODS omega-3 review). Ones formulas incorporate EPA/DHA at clinically relevant doses calibrated to a user's baseline intake and inflammatory markers.
Immune-C Blend — Vitamin C at therapeutic doses supports NK cell function and has antioxidant activity in inflamed peritoneal tissue. For users whose immune root cause analysis shows impaired immune surveillance, Ones' Immune-C proprietary blend provides targeted immune modulation rather than a generic vitamin C supplement.
The formula architecture — 6 or 9 capsules daily, selected by the AI based on the depth of findings — ensures that these ingredients are combined without exceeding safe total capsule load, and that the specific blend composition reflects the individual's dominant mechanism, not a one-size-fits-all endo protocol.
---
Key Takeaways
- Endo belly is not primarily a food sensitivity issue — it arises from peritoneal inflammation, immune dysfunction, estrogen dominance, and dysbiosis, which is why standard dietary advice often fails.
- Constipation in endometriosis can have up to four distinct root causes including mechanical compression, enteric nervous system damage, progesterone dysregulation, and microbial dysbiosis — identifying which applies to you determines which interventions will work.
- Estrogen dominance and β-glucuronidase activity create a self-reinforcing cycle of fluid retention and gut swelling that requires addressing the microbiome, not just hormones in isolation.
- Mast cell dysregulation links endometriosis to seasonal allergy worsening and gut swelling — this is a real immune mechanism, not coincidence, and targeted histamine support can reduce bloating independently of dietary changes.
- Biomarker testing beyond standard GI panels — including hs-CRP, luteal progesterone, plasma histamine, and stool microbiome — is the most reliable way to identify your dominant driver.
- Precision supplementation matched to your specific mechanism outperforms generic digestive support; platforms like Ones that cross-reference lab findings with symptom patterns can identify whether your formula should prioritize anti-inflammatory, immune, or histamine-focused ingredients.
---
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider before making any changes to your supplement protocol or medical treatment plan.